Modeling human neurodegenerative diseases in transgenic systems

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Transgenic systems are essential tools for investigating the cellular and molecular mechanisms underlying human neurodegenerative diseases.
• A broad spectrum of model organisms, from bacteria to non-human primates, are employed to study these complex conditions.

Purpose of the Study:

• To review commonly used transgenic model organisms and their preparation methodologies.
• To provide examples of transgenic models for neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's disease.
• To illustrate the impact of transgenic modeling on neurodegenerative disease research using Alzheimer's disease as a case study.

Main Methods:

• Review of existing literature on transgenic model organisms.
• Discussion of methodologies for creating transgenic organisms.
• Case study analysis of transgenic modeling in Alzheimer's disease research.

Main Results:

• Identification of key model organisms (e.g., *E. coli*, *C. elegans*, *D. melanogaster*, rodents, non-human primates) used in neurodegenerative disease research.
• Overview of techniques for generating transgenic organisms.
• Demonstration of how transgenic models have advanced the understanding and therapeutic development for diseases like Alzheimer's disease.

Conclusions:

• Transgenic models are invaluable for dissecting the pathophysiology of neurodegenerative disorders.
• These models have significantly contributed to the development of potential therapeutic interventions.
• The strategic application of transgenic technology continues to drive progress in neurodegenerative disease research.